迈威生物: 迈威生物关于变更经营范围、修订《公司章程》并办理工商变更登记的公告

Core Viewpoint - The company plans to expand its business scope to include medical research, drug production, and related activities, requiring amendments to its articles of association and subsequent registration with the industrial and commercial authorities [1][2]. Summary by Relevant Sections Business Scope Changes - The company intends to add medical research and experimental development, drug production, and other related activities to its existing business scope [1]. - The revised business scope includes general projects such as technical services, technology development, medical research, gene diagnosis and treatment technology development, and various medical device rentals [1][2]. Articles of Association Amendments - The amendments to the articles of association will reflect the new business scope and will require approval from the company's shareholders [1]. - Other contents of the articles of association will remain unchanged, and the final approved content will be based on the registration authority's confirmation [2]. Shareholder Meeting - The board of directors will seek authorization from the shareholder meeting to allow management and authorized representatives to handle the necessary registration and filing related to the business scope changes [2].